You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A research agenda to promote affordable and quality assured medicines
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, March 2014
|
| DOI | 10.1186/2052-3211-7-2 |
| Pubmed ID | |
| Authors |
Warren A Kaplan, Veronika J Wirtz |
| Abstract |
Promoting generic medicines to increase access to essential medicines is relevant to achieve the Millennium Development Goal (MDGs) and post 2015 goals. There are several barriers to encouraging wider use of generic medicines in health systems, e.g. the widely-held perception that low price equals low quality and misalignment of provider and consumer incentives. Overcoming the complex barriers and other challenges can be re-formulated as a 'generic medicine evidence-based policy agenda': (1) What policy and strategies can increase consumer trust in the quality of all medicines granted market authority including generic products? (2) Are there differences in prices between branded and unbranded generics? (3) What are synergies between policies that can enhance promoting of generic medicines effectively? Evaluating the policies promoting generic medicines will be critical to create evidence that countries can use to implement policies in their local settings. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 24 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 25% |
| Student > Master | 4 | 17% |
| Student > Postgraduate | 3 | 13% |
| Student > Doctoral Student | 2 | 8% |
| Student > Bachelor | 1 | 4% |
| Other | 3 | 13% |
| Unknown | 5 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 25% |
| Medicine and Dentistry | 4 | 17% |
| Social Sciences | 3 | 13% |
| Economics, Econometrics and Finance | 2 | 8% |
| Nursing and Health Professions | 2 | 8% |
| Other | 4 | 17% |
| Unknown | 3 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2014.
All research outputs
#18,373,576
of 22,757,090 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#354
of 405 outputs
Outputs of similar age
#160,971
of 221,254 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 2 outputs
Altmetric has tracked 22,757,090 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,254 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them